Page last updated: 2024-08-25

acamprosate and Cirrhosis, Liver

acamprosate has been researched along with Cirrhosis, Liver in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Cheng, A; Habtemariam, Z; Kelleher, C; Lewis, H; Lovendoski, J; Strathie, K; Tyson, LD1
Giri, S; Sundaram, S1
Lewis, H; Tyson, LD1
Falker, C; Garcia-Tsao, G; Kaplan, DE; Mahmud, N; Rabiee, A; Taddei, T1
Borro, P; Leone, S; Testino, G1
Opsomer, L; Potgieter, AS1

Other Studies

6 other study(ies) available for acamprosate and Cirrhosis, Liver

ArticleYear
Acamprosate may be safer than baclofen for the treatment of alcohol use disorder in patients with cirrhosis: a first description of use in real-world clinical practice.
    European journal of gastroenterology & hepatology, 2022, 05-01, Volume: 34, Issue:5

    Topics: Acamprosate; Alcohol Drinking; Alcoholism; Baclofen; Humans; Liver Cirrhosis; Retrospective Studies

2022
Acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?
    European journal of gastroenterology & hepatology, 2022, 06-01, Volume: 34, Issue:6

    Topics: Acamprosate; Alcohol Drinking; Alcoholism; Baclofen; Humans; Liver Cirrhosis

2022
Response to 'acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?'
    European journal of gastroenterology & hepatology, 2022, 09-01, Volume: 34, Issue:9

    Topics: Acamprosate; Alcohol Drinking; Alcoholism; Baclofen; Humans; Liver Cirrhosis

2022
Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis.
    Hepatology communications, 2023, 04-01, Volume: 7, Issue:4

    Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Naltrexone; Retrospective Studies

2023
Liver Disease and Hepatocellular Carcinoma in Alcoholics: The Role of Anticraving Therapy.
    Current drug targets, 2016, Volume: 17, Issue:2

    Topics: Acamprosate; Alcohol Deterrents; Alcoholics; Alcoholism; Baclofen; Carcinoma, Hepatocellular; Drug Combinations; Humans; Liver Cirrhosis; Liver Neoplasms; Pyridoxine; Pyrrolidonecarboxylic Acid; Risk Factors; Taurine

2016
Acamprosate as cause of erythema multiforme contested.
    Lancet (London, England), 1992, Oct-03, Volume: 340, Issue:8823

    Topics: Acamprosate; Alcoholism; Erythema Multiforme; Female; Herpes Genitalis; Humans; Liver Cirrhosis; Taurine; Vulvar Diseases

1992